Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Non-opioid Pain Patches Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Non-opioid Pain Patches Market Status and Forecast (2016-2027)
      • 1.3.2 Global Non-opioid Pain Patches Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Non-opioid Pain Patches Supply by Company

    • 2.1 Global Non-opioid Pain Patches Sales Volume by Company
    • 2.2 Global Non-opioid Pain Patches Sales Value by Company
    • 2.3 Global Non-opioid Pain Patches Price by Company
    • 2.4 Non-opioid Pain Patches Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Non-opioid Pain Patches Market Status by Category

    • 3.1 Non-opioid Pain Patches Category Introduction
      • 3.1.1 Lidocaine Patch
      • 3.1.2 Diclofenac Patch
      • 3.1.3 Methyl Salicylate Patch
      • 3.1.4 Capsaicin Patch
      • 3.1.5 Ketoprofen Patch
      • 3.1.6 Others
    • 3.2 Global Non-opioid Pain Patches Market by Category
      • 3.2.1 Global Non-opioid Pain Patches Sales Volume by Category (2016-2021)
      • 3.2.2 Global Non-opioid Pain Patches Sales Value by Category (2016-2021)
      • 3.2.3 Global Non-opioid Pain Patches Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Non-opioid Pain Patches Market Status by End User/Segment

    • 4.1 Non-opioid Pain Patches Segment by End User/Segment
      • 4.1.1 Hospital Pharmacies
      • 4.1.2 Independent Pharmacies & Drug Stores
      • 4.1.3 Online Pharmacies
    • 4.2 Global Non-opioid Pain Patches Market by End User/Segment
      • 4.2.1 Global Non-opioid Pain Patches Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Non-opioid Pain Patches Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Non-opioid Pain Patches Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Non-opioid Pain Patches Market Status by Region

    • 5.1 Global Non-opioid Pain Patches Market by Region
      • 5.1.1 Global Non-opioid Pain Patches Sales Volume by Region
      • 5.1.2 Global Non-opioid Pain Patches Sales Value by Region
    • 5.2 North America Non-opioid Pain Patches Market Status
    • 5.3 Europe Non-opioid Pain Patches Market Status
    • 5.4 Asia Pacific Non-opioid Pain Patches Market Status
    • 5.5 Central & South America Non-opioid Pain Patches Market Status
    • 5.6 Middle East & Africa Non-opioid Pain Patches Market Status

    6 North America Non-opioid Pain Patches Market Status

    • 6.1 North America Non-opioid Pain Patches Market by Country
      • 6.1.1 North America Non-opioid Pain Patches Sales Volume by Country (2016-2021)
      • 6.1.2 North America Non-opioid Pain Patches Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Non-opioid Pain Patches Market Status

    • 7.1 Europe Non-opioid Pain Patches Market by Country
      • 7.1.1 Europe Non-opioid Pain Patches Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Non-opioid Pain Patches Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Non-opioid Pain Patches Market Status

    • 8.1 Asia Pacific Non-opioid Pain Patches Market by Country
      • 8.1.1 Asia Pacific Non-opioid Pain Patches Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Non-opioid Pain Patches Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Non-opioid Pain Patches Market Status

    • 9.1 Central & South America Non-opioid Pain Patches Market by Country
      • 9.1.1 Central & South America Non-opioid Pain Patches Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Non-opioid Pain Patches Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Non-opioid Pain Patches Market Status

    • 10.1 Middle East & Africa Non-opioid Pain Patches Market by Country
      • 10.1.1 Middle East & Africa Non-opioid Pain Patches Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Non-opioid Pain Patches Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Non-opioid Pain Patches Manufacturing Cost Analysis
    • 11.5 Non-opioid Pain Patches Sales Channel and Distributors Analysis
      • 11.5.1 Non-opioid Pain Patches Sales Channel
      • 11.5.2 Non-opioid Pain Patches Distributors
    • 11.6 Non-opioid Pain Patches Downstream Major Buyers

    12 Global Non-opioid Pain Patches Market Forecast by Category and by End User/Segment

    • 12.1 Global Non-opioid Pain Patches Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Non-opioid Pain Patches Forecast by Category
      • 12.2.1 Global Non-opioid Pain Patches Sales Volume Forecast by Category
      • 12.2.2 Global Non-opioid Pain Patches Sales Value Forecast by Category
      • 12.2.3 Global Non-opioid Pain Patches Price Forecast by Category
    • 12.3 Global Non-opioid Pain Patches Forecast by End User/Segment
      • 12.3.1 Global Non-opioid Pain Patches Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Non-opioid Pain Patches Sales Value Forecast by End User/Segment
      • 12.3.3 Global Non-opioid Pain Patches Price Forecast by End User/Segment

    13 Global Non-opioid Pain Patches Market Forecast by Region/Country

    • 13.1 Global Non-opioid Pain Patches Market Forecast by Region (2022-2027)
      • 13.1.1 Global Non-opioid Pain Patches Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Non-opioid Pain Patches Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Teva Pharmaceutical Industries
      • 14.1.1 Company Information
      • 14.1.2 Non-opioid Pain Patches Product Introduction
      • 14.1.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Teikoku Seiyaku
      • 14.2.1 Company Information
      • 14.2.2 Non-opioid Pain Patches Product Introduction
      • 14.2.3 Teikoku Seiyaku Non-opioid Pain Patches Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 TEH SENG Pharmaceutical
      • 14.3.1 Company Information
      • 14.3.2 Non-opioid Pain Patches Product Introduction
      • 14.3.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Pfizer
      • 14.4.1 Company Information
      • 14.4.2 Non-opioid Pain Patches Product Introduction
      • 14.4.3 Pfizer Non-opioid Pain Patches Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Novartis AG
      • 14.5.1 Company Information
      • 14.5.2 Non-opioid Pain Patches Product Introduction
      • 14.5.3 Novartis AG Non-opioid Pain Patches Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Mylan N.V.
      • 14.6.1 Company Information
      • 14.6.2 Non-opioid Pain Patches Product Introduction
      • 14.6.3 Mylan N.V. Non-opioid Pain Patches Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Johnson & Johnson
      • 14.7.1 Company Information
      • 14.7.2 Non-opioid Pain Patches Product Introduction
      • 14.7.3 Johnson & Johnson Non-opioid Pain Patches Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 IBSA Institut Biochimque SA
      • 14.8.1 Company Information
      • 14.8.2 Non-opioid Pain Patches Product Introduction
      • 14.8.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Hisamitsu Pharmaceutical
      • 14.9.1 Company Information
      • 14.9.2 Non-opioid Pain Patches Product Introduction
      • 14.9.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 GlaxoSmithKline
      • 14.10.1 Company Information
      • 14.10.2 Non-opioid Pain Patches Product Introduction
      • 14.10.3 GlaxoSmithKline Non-opioid Pain Patches Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Endo International
    • 14.12 Allergan PLC
    • 14.13 Acorda Therapeutics

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Non-opioid Pain Patches market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Non-opioid Pain Patches market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Lidocaine Patch
      Diclofenac Patch
      Methyl Salicylate Patch
      Capsaicin Patch
      Ketoprofen Patch
      Others

      Segmented by End User/Segment
      Hospital Pharmacies
      Independent Pharmacies & Drug Stores
      Online Pharmacies

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Teva Pharmaceutical Industries
      Teikoku Seiyaku
      TEH SENG Pharmaceutical
      Pfizer
      Novartis AG
      Mylan N.V.
      Johnson & Johnson
      IBSA Institut Biochimque SA
      Hisamitsu Pharmaceutical
      GlaxoSmithKline
      Endo International
      Allergan PLC
      Acorda Therapeutics
      Buy now